Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity.
|
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
57JnfgQLVVkATcFs